uniQure N.V. (QURE)
USD 8.91
(-8.62%)
USD 8.91
(-8.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 624.01 Million USD | 172.55% |
| 2022 | 228.95 Million USD | 7.29% |
| 2021 | 213.4 Million USD | 121.17% |
| 2020 | 96.49 Million USD | -23.16% |
| 2019 | 125.57 Million USD | 33.16% |
| 2018 | 94.3 Million USD | -20.71% |
| 2017 | 118.93 Million USD | -6.08% |
| 2016 | 126.63 Million USD | -5.54% |
| 2015 | 134.05 Million USD | 109.18% |
| 2014 | 64.08 Million USD | 38.93% |
| 2013 | 46.12 Million USD | 479.87% |
| 2012 | 7.95 Million USD | -26.91% |
| 2011 | 10.88 Million USD | -9.52% |
| 2010 | 12.02 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 623.29 Million USD | -0.12% |
| 2024 Q2 | 633.73 Million USD | 1.68% |
| 2024 Q3 | 589.98 Million USD | -6.9% |
| 2023 Q3 | 602.76 Million USD | 2.26% |
| 2023 Q4 | 624.01 Million USD | 3.53% |
| 2023 Q2 | 589.44 Million USD | 170.1% |
| 2023 FY | 624.01 Million USD | 172.55% |
| 2023 Q1 | 218.23 Million USD | -4.68% |
| 2022 Q2 | 214.72 Million USD | 1.69% |
| 2022 Q1 | 211.14 Million USD | -1.06% |
| 2022 FY | 228.95 Million USD | 7.29% |
| 2022 Q4 | 228.95 Million USD | 5.48% |
| 2022 Q3 | 217.06 Million USD | 1.09% |
| 2021 Q1 | 135.16 Million USD | 40.08% |
| 2021 FY | 213.4 Million USD | 121.17% |
| 2021 Q4 | 213.4 Million USD | 16.06% |
| 2021 Q3 | 183.87 Million USD | 22.05% |
| 2021 Q2 | 150.65 Million USD | 11.46% |
| 2020 Q1 | 119.09 Million USD | -5.16% |
| 2020 Q4 | 96.49 Million USD | -21.31% |
| 2020 FY | 96.49 Million USD | -23.16% |
| 2020 Q2 | 119.83 Million USD | 0.62% |
| 2020 Q3 | 122.61 Million USD | 2.32% |
| 2019 Q2 | 121.02 Million USD | 8.17% |
| 2019 Q3 | 121.36 Million USD | 0.28% |
| 2019 Q1 | 111.88 Million USD | 18.64% |
| 2019 Q4 | 125.57 Million USD | 3.47% |
| 2019 FY | 125.57 Million USD | 33.16% |
| 2018 FY | 94.3 Million USD | -20.71% |
| 2018 Q3 | 81.2 Million USD | -9.89% |
| 2018 Q2 | 90.12 Million USD | -2.01% |
| 2018 Q4 | 94.3 Million USD | 16.12% |
| 2018 Q1 | 91.97 Million USD | -23.54% |
| 2017 Q1 | 123.9 Million USD | -2.15% |
| 2017 FY | 118.93 Million USD | -6.08% |
| 2017 Q4 | 120.28 Million USD | 0.76% |
| 2017 Q3 | 119.37 Million USD | -8.65% |
| 2017 Q2 | 130.67 Million USD | 5.46% |
| 2016 Q4 | 126.63 Million USD | -4.63% |
| 2016 FY | 126.63 Million USD | -5.54% |
| 2016 Q3 | 132.78 Million USD | -2.56% |
| 2016 Q1 | 137.83 Million USD | 2.81% |
| 2016 Q2 | 136.27 Million USD | -1.13% |
| 2015 Q3 | 139.74 Million USD | 10.25% |
| 2015 Q2 | 126.75 Million USD | 107.69% |
| 2015 FY | 134.05 Million USD | 109.18% |
| 2015 Q4 | 134.05 Million USD | -4.07% |
| 2015 Q1 | 61.03 Million USD | -4.77% |
| 2014 Q1 | 53.58 Million USD | 16.16% |
| 2014 Q3 | 63.6 Million USD | 0.46% |
| 2014 Q2 | 63.31 Million USD | 18.17% |
| 2014 Q4 | 64.08 Million USD | 0.75% |
| 2014 FY | 64.08 Million USD | 38.93% |
| 2013 Q2 | 62.12 Million USD | 0.0% |
| 2013 Q4 | 46.12 Million USD | 5.67% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 46.12 Million USD | 479.87% |
| 2013 Q3 | 43.65 Million USD | -29.73% |
| 2012 FY | 7.95 Million USD | -26.91% |
| 2012 Q4 | 7.95 Million USD | 0.0% |
| 2011 FY | 10.88 Million USD | -9.52% |
| 2010 FY | 12.02 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -85.844% |
| Alkermes plc | 933.53 Million USD | 33.155% |
| Agenus Inc. | 462.29 Million USD | -34.983% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 84.594% |
| Aptorum Group Limited | 5.25 Million USD | -11770.841% |
| Ardelyx, Inc. | 130.76 Million USD | -377.214% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -30.441% |
| Bicycle Therapeutics plc | 224.41 Million USD | -178.068% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -379.24% |
| ChromaDex Corporation | 26.5 Million USD | -2254.078% |
| Chimerix, Inc. | 19.74 Million USD | -3060.39% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1673.935% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -759.921% |
| CRISPR Therapeutics AG | 346.76 Million USD | -79.953% |
| Precision BioSciences, Inc. | 140.92 Million USD | -342.818% |
| Dyadic International, Inc. | 2.34 Million USD | -26560.062% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3737.047% |
| Fortress Biotech, Inc. | 165.93 Million USD | -276.053% |
| Lantern Pharma Inc. | 2.73 Million USD | -22677.06% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -772.998% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -17583.979% |
| Incyte Corporation | 1.59 Billion USD | 60.809% |
| IO Biotech, Inc. | 17.55 Million USD | -3454.449% |
| Jaguar Health, Inc. | 45.86 Million USD | -1260.526% |
| Novavax, Inc. | 2.57 Billion USD | 75.741% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1630.598% |
| Opthea Limited | 264.6 Million USD | -135.834% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -377.418% |
| ContextLogic Inc. | 206 Million USD | -202.922% |
| MiMedx Group, Inc. | 96.33 Million USD | -547.793% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1199.444% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -17583.168% |
| NextCure, Inc. | 14.99 Million USD | -4060.959% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -15338.372% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -9245.799% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1235.114% |
| Vaxcyte, Inc. | 167.44 Million USD | -272.662% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1776.234% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -165.298% |
| Pharming Group N.V. | 244.07 Million USD | -155.669% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -5134.181% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -388.312% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -9344.417% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -9344.417% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -657.001% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -9293.632% |
| Acelyrin, Inc. | 86.35 Million USD | -622.637% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -47929.503% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4239.794% |
| Summit Therapeutics Inc. | 125.25 Million USD | -398.191% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6483.173% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1087.002% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -807.308% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -311.861% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -31802.812% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -46623.257% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -175.102% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6561.887% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -174.36% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -26.19% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5617.601% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2168.253% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -5055.18% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -28.24% |
| Immix Biopharma, Inc. | 3.72 Million USD | -16666.668% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1550.32% |
| MEI Pharma, Inc. | 8.35 Million USD | -7368.809% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2050.677% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -79.532% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -327.794% |
| Fortress Biotech, Inc. | 165.93 Million USD | -276.053% |
| Precigen, Inc. | 41.64 Million USD | -1398.461% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1149.788% |
| AlloVir, Inc. | 45.01 Million USD | -1286.247% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -378.773% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -352.844% |
| ImmuCell Corporation | 18.81 Million USD | -3216.599% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2110.795% |
| Onconetix, Inc. | 23.18 Million USD | -2591.955% |
| PureTech Health plc | 125.58 Million USD | -396.898% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6872.279% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1720.253% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -25422.249% |
| Seer, Inc. | 39.36 Million USD | -1485.213% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -909.184% |
| Innoviva, Inc. | 568.55 Million USD | -9.756% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2191.828% |
| ESSA Pharma Inc. | 3.49 Million USD | -17754.258% |
| GlycoMimetics, Inc. | 6.9 Million USD | -8941.036% |
| GT Biopharma, Inc. | 6.63 Million USD | -9307.794% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -136.022% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -129.177% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -642.65% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -6284.479% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2196.805% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -19244.79% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -745.932% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3847.314% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5552.507% |
| Soligenix, Inc. | 7.27 Million USD | -8477.694% |
| Century Therapeutics, Inc. | 175.94 Million USD | -254.675% |
| Kura Oncology, Inc. | 51.66 Million USD | -1107.888% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -414.519% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -14998.451% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -9335.027% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -147.04% |
| Autolus Therapeutics plc | 263.9 Million USD | -136.454% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5853.244% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -602.242% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1230.559% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -76.848% |
| GRI Bio, Inc. | 2.69 Million USD | -23037.523% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -76978.874% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1907.073% |
| IGM Biosciences, Inc. | 220.17 Million USD | -183.417% |
| INmune Bio, Inc. | 18.86 Million USD | -3208.34% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -143.302% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2242.254% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -22855.327% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -18923.427% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -967.52% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -548.945% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -135.715% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 24.18% |
| Verastem, Inc. | 71.18 Million USD | -776.616% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1168.95% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1517.551% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1175.278% |
| Histogen Inc. | 5.69 Million USD | -10853.467% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -14128.801% |
| Surrozen, Inc. | 8.14 Million USD | -7561.375% |
| Organovo Holdings, Inc. | 2.74 Million USD | -22608.115% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -198722.079% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1009.764% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3679.185% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1121.101% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -75367.15% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -392.42% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5670.692% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -313.562% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -23833.12% |
| Apollomics, Inc. | 14.15 Million USD | -4309.093% |
| Amarin Corporation plc | 279.58 Million USD | -123.193% |
| Mesoblast Limited | 188.79 Million USD | -230.522% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4310.652% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -245.166% |
| Synaptogenix, Inc. | 5.52 Million USD | -11185.333% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -9286.567% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -266.837% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7192.333% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -35408.222% |
| Exelixis, Inc. | 678.44 Million USD | 8.022% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2517.31% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -280.393% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -5.017% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5742.763% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -38333.903% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1503.049% |
| Gritstone bio, Inc. | 125.91 Million USD | -395.572% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4151.969% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -12163.013% |
| Avid Bioservices, Inc. | 275.66 Million USD | -126.366% |
| Insmed Incorporated | 1.66 Billion USD | 62.448% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -8010.437% |
| MediWound Ltd. | 27.18 Million USD | -2195.285% |
| OmniAb, Inc. | 87.4 Million USD | -613.981% |
| Alector, Inc. | 487.66 Million USD | -27.96% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -54.668% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3286.806% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1526.193% |
| Zai Lab Limited | 240.17 Million USD | -159.816% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 0.958% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2035.077% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -556.33% |
| Immunic, Inc. | 25.36 Million USD | -2359.867% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -801.293% |
| Veracyte, Inc. | 93.71 Million USD | -565.84% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -23747.802% |
| FibroGen, Inc. | 585.72 Million USD | -6.537% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3489.823% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -95450.748% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -10933.925% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 91.85% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7511.844% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -642.685% |
| TG Therapeutics, Inc. | 169.08 Million USD | -269.056% |
| Galecto, Inc. | 5.89 Million USD | -10483.769% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -7432.822% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 76.168% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2065.079% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4844.291% |
| XBiotech Inc. | 8.39 Million USD | -7331.452% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4151.969% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1073.409% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -71.856% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2221.154% |
| Theravance Biopharma, Inc. | 169 Million USD | -269.233% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 48.666% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -24.698% |
| Vaxxinity, Inc. | 30.94 Million USD | -1916.607% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 35.833% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -10246.674% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 16.265% |
| NexImmune, Inc. | 5.08 Million USD | -12173.614% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -167920.754% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -20194.304% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 91.22% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -12007.399% |
| Scopus BioPharma Inc. | 7.45 Million USD | -8271.112% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2273.237% |
| Ainos, Inc. | 7.39 Million USD | -8339.278% |
| Pluri Inc. | 34.11 Million USD | -1729.324% |
| Prothena Corporation plc | 135.01 Million USD | -362.178% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -156.689% |
| Celularity Inc. | 102.92 Million USD | -506.262% |
| Rallybio Corporation | 9.43 Million USD | -6513.173% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2452.747% |
| MeiraGTx Holdings plc | 319.99 Million USD | -95.011% |
| Omeros Corporation | 403.25 Million USD | -54.747% |
| Humacyte, Inc. | 114.67 Million USD | -444.154% |
| Immunocore Holdings plc | 228.15 Million USD | -173.503% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -12700.39% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -713.16% |
| Blueprint Medicines Corporation | 918.64 Million USD | 32.072% |
| CalciMedica, Inc. | 4.02 Million USD | -15392.031% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3475.63% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -304.831% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -627.151% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -124.635% |
| Pulmatrix, Inc. | 15.96 Million USD | -3809.159% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3856.248% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2436.044% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -148.803% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1128.722% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 48.455% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1863.374% |
| Nutriband Inc. | 1.07 Million USD | -57737.428% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5768.701% |
| Vor Biopharma Inc. | 59.1 Million USD | -955.798% |
| Roivant Sciences Ltd. | 773.95 Million USD | 19.372% |
| Evogene Ltd. | 17.99 Million USD | -3368.699% |
| ProKidney Corp. | 29.21 Million USD | -2035.881% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -766.946% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -88415.468% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 66.964% |
| CorMedix Inc. | 11.91 Million USD | -5136.145% |
| BioLineRx Ltd. | 50.7 Million USD | -1130.758% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -317.519% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -605.577% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1169.312% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1903.123% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3374.106% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -400.673% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -10936.77% |
| MediciNova, Inc. | 3.89 Million USD | -15935.218% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3313.857% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -41383.978% |
| GeoVax Labs, Inc. | 3.51 Million USD | -17628.412% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -57.081% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1933.297% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 77.073% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3809.404% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1899.997% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -963.355% |
| Absci Corporation | 58.3 Million USD | -970.285% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3176.034% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1846.289% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -745.669% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -613.303% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1747.85% |
| Allakos Inc. | 74.79 Million USD | -734.328% |
| Imunon, Inc. | 8.53 Million USD | -7215.214% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2673.295% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -443.514% |
| BioAtla, Inc. | 48.98 Million USD | -1173.872% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5742.763% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -22354.804% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -377.795% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4289.863% |
| XOMA Corporation | 145.58 Million USD | -328.643% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1753.614% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -807.545% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1874.931% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -909.364% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1287.788% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1189.242% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -21642.822% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7549.15% |
| Akari Therapeutics, Plc | 4.58 Million USD | -13512.98% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3418.944% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 62.168% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -154395.331% |
| UroGen Pharma Ltd. | 243.52 Million USD | -156.246% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -94.346% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -22496.628% |
| Orgenesis Inc. | 35.53 Million USD | -1656.069% |
| Entera Bio Ltd. | 1.37 Million USD | -45151.559% |
| GH Research PLC | 6.7 Million USD | -9212.327% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -9076.75% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3214.666% |
| Xencor, Inc. | 283.55 Million USD | -120.067% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -20800.433% |
| Replimune Group, Inc. | 113.21 Million USD | -451.185% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -16508.95% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -502.742% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -154395.331% |
| Portage Biotech Inc. | 4.45 Million USD | -13922.899% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -41383.978% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2607.241% |
| OncoCyte Corporation | 49.29 Million USD | -1165.81% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -14984.564% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -78148.466% |
| Purple Biotech Ltd. | 10 Million USD | -6137.071% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -10684.981% |
| scPharmaceuticals Inc. | 57.26 Million USD | -989.78% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4937.278% |
| HilleVax, Inc. | 78.9 Million USD | -690.808% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -12256.812% |
| Tharimmune, Inc. | 1.81 Million USD | -34280.341% |
| Genprex, Inc. | 3.25 Million USD | -19075.756% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2201.04% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -11817.857% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -302821.845% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -173940.575% |
| OKYO Pharma Limited | 7.42 Million USD | -8309.001% |
| Savara Inc. | 37.19 Million USD | -1577.831% |
| Curis, Inc. | 57.61 Million USD | -983.141% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2270.005% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1491.894% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -43114.612% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2897.353% |
| BeiGene, Ltd. | 2.23 Billion USD | 72.064% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2831.07% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -137.815% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2833.247% |
| Erasca, Inc. | 78.61 Million USD | -693.806% |
| bluebird bio, Inc. | 424.62 Million USD | -46.958% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -95133.437% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 66.984% |
| DBV Technologies S.A. | 42.8 Million USD | -1357.988% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -95133.437% |
| Moderna, Inc. | 4.57 Billion USD | 86.351% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8820.929% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -37582.307% |
| Molecular Templates, Inc. | 31.17 Million USD | -1901.922% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3555.647% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -6.107% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -401.2% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2174.37% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1611.705% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1021.63% |
| MacroGenics, Inc. | 154.2 Million USD | -304.663% |
| RenovoRx, Inc. | 4.46 Million USD | -13872.66% |
| Adicet Bio, Inc. | 37.12 Million USD | -1581.086% |
| Prime Medicine, Inc. | 60.78 Million USD | -926.685% |
| Aditxt, Inc. | 28.53 Million USD | -2087.119% |
| Adagene Inc. | 45.16 Million USD | -1281.51% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -345232.345% |
| Quantum-Si incorporated | 26.63 Million USD | -2243.205% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 10.543% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -20410.492% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -442.809% |
| SciSparc Ltd. | 1.59 Million USD | -39023.448% |
| Vericel Corporation | 127.7 Million USD | -388.641% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -11113.493% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -631.06% |
| Generation Bio Co. | 171.63 Million USD | -263.584% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5302.762% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1391.762% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -146.943% |
| Invivyd, Inc. | 51.71 Million USD | -1106.697% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -578.451% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -9492.543% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -726.559% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -61018.413% |
| 2seventy bio, Inc. | 310.12 Million USD | -101.215% |
| ADMA Biologics, Inc. | 193.97 Million USD | -221.699% |
| Clene Inc. | 38.95 Million USD | -1502.062% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1627.012% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -142.832% |
| GeoVax Labs, Inc. | 3.51 Million USD | -17628.412% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -227.977% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -5023.451% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -214.649% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -5017.091% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1197.04% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1080.937% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -68.72% |
| Evaxion Biotech A/S | 17.61 Million USD | -3442.045% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -287.76% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -307.36% |
| Trevena, Inc. | 48.26 Million USD | -1192.982% |
| Surrozen, Inc. | 8.14 Million USD | -7561.375% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2789.646% |
| Cingulate Inc. | 10.36 Million USD | -5922.847% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -22591.6% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1573.332% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -17299.011% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4645.392% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -96.727% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2411.244% |
| Clearmind Medicine Inc. | 3.61 Million USD | -17185.807% |
| Kronos Bio, Inc. | 54.2 Million USD | -1051.305% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1226.486% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2641.768% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3009.058% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2651.837% |
| ImmunityBio, Inc. | 1.09 Billion USD | 42.771% |
| Korro Bio, Inc. | 51.75 Million USD | -1105.787% |
| Kineta, Inc. | 7.22 Million USD | -8540.529% |
| BioVie Inc. | 9.7 Million USD | -6331.773% |
| Codexis, Inc. | 49.94 Million USD | -1149.387% |
| Celularity Inc. | 102.92 Million USD | -506.262% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -548.352% |
| Celcuity Inc. | 51.45 Million USD | -1112.863% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -180673.42% |
| Cibus, Inc. | 206.11 Million USD | -202.75% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1369.144% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2269.183% |
| IN8bio, Inc. | 8.77 Million USD | -7013.76% |
| Kodiak Sciences Inc. | 213.59 Million USD | -192.156% |
| Annexon, Inc. | 47.11 Million USD | -1224.375% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -596.909% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -547.511% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4458.543% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 76.03% |
| Eyenovia, Inc. | 19.78 Million USD | -3054.753% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -252.382% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8024.19% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2489.398% |
| Arcellx, Inc. | 339.75 Million USD | -83.669% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -5144.739% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -154.141% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6425.348% |
| Moolec Science SA | 13.94 Million USD | -4374.744% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1346.095% |
| Geron Corporation | 146.12 Million USD | -327.039% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1134.899% |
| Royalty Pharma plc | 6.29 Billion USD | 90.091% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1468.833% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -211858.656% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -25263.718% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -229.896% |
| Humacyte, Inc. | 114.67 Million USD | -444.154% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2048.012% |
| 89bio, Inc. | 59.96 Million USD | -940.673% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2258.081% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -52075.502% |
| Genelux Corporation | 8.42 Million USD | -7311.152% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -9001.794% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -357.764% |
| Notable Labs, Ltd. | 4.42 Million USD | -13995.753% |
| Liquidia Corporation | 73.13 Million USD | -753.208% |
| Mustang Bio, Inc. | 17.61 Million USD | -3441.739% |
| Immunovant, Inc. | 48.95 Million USD | -1174.679% |
| Quantum-Si incorporated | 26.63 Million USD | -2243.205% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1525.769% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -20010.184% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -744.856% |
| Acasti Pharma Inc. | 11.55 Million USD | -5299.489% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2660.202% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -22855.327% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1592.163% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -45688.066% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -10136.532% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2412.66% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2591.593% |
| PepGen Inc. | 34.63 Million USD | -1701.909% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -5038.496% |
| United Therapeutics Corporation | 1.18 Billion USD | 47.215% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8834.98% |
| Solid Biosciences Inc. | 38.45 Million USD | -1522.599% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7192.333% |
| Immuneering Corporation | 12 Million USD | -5096.54% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -198722.079% |
| Silo Pharma, Inc. | 1.56 Million USD | -39664.923% |
| Belite Bio, Inc | 4.21 Million USD | -14718.784% |
| XOMA Corporation | 145.58 Million USD | -328.643% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -25600.947% |
| Bionomics Limited | 10.15 Million USD | -6042.693% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2803.629% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2623.428% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4296.048% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -345232.345% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -266.673% |
| Forte Biosciences, Inc. | 3.66 Million USD | -16921.795% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -239370.342% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -9148.837% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8024.19% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3489.823% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5804.798% |
| Altimmune, Inc. | 16.54 Million USD | -3672.559% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -1.022% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2623.428% |
| Compugen Ltd. | 55.77 Million USD | -1018.815% |
| Peak Bio, Inc. | 20.75 Million USD | -2906.833% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -464.912% |
| Benitec Biopharma Inc. | 4.96 Million USD | -12475.957% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -295.342% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -730.1% |
| Zura Bio Limited | 21.29 Million USD | -2830.767% |
| PolyPid Ltd. | 17.46 Million USD | -3472.355% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -455.182% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -730.1% |
| Instil Bio, Inc. | 99.8 Million USD | -525.263% |
| argenx SE | 444.95 Million USD | -40.244% |
| Immunome, Inc. | 28.65 Million USD | -2077.469% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -7384.935% |
| Verona Pharma plc | 58.84 Million USD | -960.517% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4211.608% |
| Shattuck Labs, Inc. | 14.85 Million USD | -4099.603% |
| CervoMed Inc. | 2.59 Million USD | -23940.055% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -12703.016% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4799.647% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5823.294% |
| Moolec Science SA | 13.94 Million USD | -4374.744% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -26527.606% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1022.431% |
| AnaptysBio, Inc. | 364.28 Million USD | -71.299% |
| Design Therapeutics, Inc. | 11.95 Million USD | -5119.296% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4819.734% |
| NeurAxis, Inc. | 1.91 Million USD | -32524.367% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1503.008% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4580.26% |
| Achilles Therapeutics plc | 19.08 Million USD | -3169.34% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4211.608% |
| 180 Life Sciences Corp. | 5.38 Million USD | -11483.345% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2545.495% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2641.768% |
| Nutriband Inc. | 1.07 Million USD | -57737.428% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1939.411% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -4200.317% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -55.509% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1821.655% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4682.086% |
| Palisade Bio, Inc. | 2.73 Million USD | -22682.731% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -11779.288% |
| Beam Therapeutics Inc. | 478.38 Million USD | -30.443% |
| Neurogene Inc. | 36.54 Million USD | -1607.349% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -56.808% |
| AEON Biopharma, Inc. | 159.88 Million USD | -290.283% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1209.589% |
| Sesen Bio, Inc. | 30.98 Million USD | -1914.004% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2303.679% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -8108.383% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -218.803% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -224.913% |
| Athira Pharma, Inc. | 30.05 Million USD | -1976.119% |
| Vaccinex, Inc. | 5.94 Million USD | -10401.834% |
| HCW Biologics Inc. | 15.05 Million USD | -4045.77% |
| XOMA Corporation | 145.58 Million USD | -328.643% |
| Nektar Therapeutics | 267.04 Million USD | -133.675% |
| Arvinas, Inc. | 644.6 Million USD | 3.193% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3418.944% |
| Merus N.V. | 102.15 Million USD | -510.879% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -326.388% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -556.033% |
| Rezolute, Inc. | 11.73 Million USD | -5218.042% |
| Clene Inc. | 38.95 Million USD | -1502.062% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -21815.55% |
| BeyondSpring Inc. | 48.26 Million USD | -1192.795% |
| Synlogic, Inc. | 32.89 Million USD | -1797.003% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -4170.3% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -38089.657% |
| Peak Bio, Inc. | 20.75 Million USD | -2906.833% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -883.342% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1471.282% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -65.679% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -526.72% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -144106.496% |
| MannKind Corporation | 721.36 Million USD | 13.495% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2693.906% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -29814.621% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -508.265% |
| Gossamer Bio, Inc. | 249.14 Million USD | -150.462% |
| CohBar, Inc. | 1.03 Million USD | -60271.136% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5737.955% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3176.034% |
| Legend Biotech Corporation | 589.93 Million USD | -5.778% |
| Mural Oncology plc | 37.92 Million USD | -1545.273% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -370.475% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -27086.438% |
| Disc Medicine, Inc. | 22.87 Million USD | -2627.952% |
| Champions Oncology, Inc. | 28.03 Million USD | -2125.857% |
| REGENXBIO Inc. | 262.22 Million USD | -137.968% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -18475.576% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4878.61% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4545.893% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2842.792% |
| Vaxart, Inc. | 34.02 Million USD | -1734.001% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2960.527% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2087.094% |
| Cellectis S.A. | 249.57 Million USD | -150.033% |
| Longeveron Inc. | 5.33 Million USD | -11592.318% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1392.19% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 74.056% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -933.692% |
| Revolution Medicines, Inc. | 262.39 Million USD | -137.815% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -29516.469% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -7134.164% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -5187.848% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4343.63% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -28910.646% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 87.883% |
| Denali Therapeutics Inc. | 122.96 Million USD | -407.485% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -11113.493% |
| Veru Inc. | 32.81 Million USD | -1801.76% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -8984.568% |
| Cingulate Inc. | 10.36 Million USD | -5922.847% |
| Passage Bio, Inc. | 39.26 Million USD | -1489.371% |
| Context Therapeutics Inc. | 4.19 Million USD | -14786.962% |
| Exicure, Inc. | 8.54 Million USD | -7199.322% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2014.745% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5850.973% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2731.174% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -282.867% |
| Nuvalent, Inc. | 31.82 Million USD | -1860.906% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -9709.11% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -890.161% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3366.772% |
| OmniAb, Inc. | 87.4 Million USD | -613.981% |
| Anew Medical, Inc. | 8.24 Million USD | -7471.393% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1529.757% |
| Lipocine Inc. | 2.63 Million USD | -23612.271% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2275.225% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1451.823% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2242.254% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -624.306% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -11453.768% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -654.129% |
| Ocugen, Inc. | 23.98 Million USD | -2501.922% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1244.666% |
| Q32 Bio Inc. | 233.12 Million USD | -167.672% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6783.069% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1066.347% |
| Equillium, Inc. | 27.95 Million USD | -2132.067% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -202.054% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -10990.388% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -10074.829% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -296.641% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -798.735% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -6156.331% |
| Dominari Holdings Inc. | 4.63 Million USD | -13363.193% |
| Edesa Biotech, Inc. | 1.84 Million USD | -33783.93% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2010.525% |
| Bio-Techne Corporation | 744.34 Million USD | 16.165% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -394.864% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -81.161% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1437.94% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2054.985% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -575.638% |
| Nkarta, Inc. | 105.6 Million USD | -490.927% |
| BioCardia, Inc. | 4.59 Million USD | -13495.185% |
| Iterum Therapeutics plc | 32.66 Million USD | -1810.535% |